ArticleScientific reports2025
Dietary Phyllanthus Emblica inclusion regulates growth, serum biochemistry, organ histology, gene expression, and resistance against Aspergillus Flavus in Nile Tilapia (Oreochromis Niloticus).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Janus Face ofVeterinary sciences · 2026Review
- Effects of DietaryAnimals : an open access journal from MDPI · 2026Article
- DietaryFrontiers in immunology · 2026Article
- EPI-DOM framework for assessing fish welfare: external and internal indicators for tilapia.Frontiers in veterinary science · 2026Article
- Impact of dietary Phyllanthus emblica on growth, immunity, antioxidant capacity, and Fusarium oxysporum resistance in red tilapia.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research aimed to explore the effect of Phyllanthus emblica powder on the growth performance, blood hematology, body composition, serum biochemistry, organ histology, gene expression and resistance of Nile Tilapia (Oreochromis niloticus) against Aspergillus flavus. A total of 240 fish (30.5 ± 2.0 g) were distributed in 12 ponds with 20 fish per pond and fed a basal diet supplemented with 0, 1%, 2% and 3% of P. emblica powder for 60 days. A challenge experiment was performed at the end of the trial. All supplemented groups showed better growth performance (final body weight, weight gain, and specific growth rates) (P < 0.05), while feed intake did not affect (P > 0.05). The feed conversion ratio enhanced by the inclusion of dietary P. emblica (P < 0.05). In terms of body composition, crude lipids decreased, while ash percentages increased after fish were fed with P. emblica (P < 0.05). Liver function decreased significantly, while protein fraction, blood hematology and digestive enzymatic profile (amylase, and lipase) were significantly increased in all treated groups. Fish fed with P. emblica exhibited a higher survival rate and increased resistance to A. flavus compared to the control diet. Diets containing P. emblica improved the histoarchitecture of hepatopancreatic and intestine of Nile Tilapia. The inclusion of P. emblica significantly upregulated the expression of CC chemokine, IL-1β, IL-8, SOD, and GPx genes, with a gradual increase in P. emblica levels in the diet (P < 0.05). In conclusion, dietary supplementation with P. emblica powder may serve as an effective strategy for promoting growth and acting as an immunostimulant in Nile Tilapia aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.